These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11020130)

  • 1. Polyradiculoneuritis after botulinum toxin therapy for cervical dystonia.
    Burguera JA; Villaroya T; López-Alemany M
    Clin Neuropharmacol; 2000; 23(4):226-8. PubMed ID: 11020130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case report of acute polyradiculoneuritis developing after multiple injections of botulinum toxin for cervical dystonia].
    Onoue H; Matsunobu A; Nagaishi A; Yukitake M; Kuroda Y
    Rinsho Shinkeigaku; 2004 Jan; 44(1):20-4. PubMed ID: 15199733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cervical dystonia with botulinum toxin in a patient with myasthenia gravis.
    Gonçalves MR; Barbosa ER; Zambon AA; Marchiori PE
    Arq Neuropsiquiatr; 1999 Sep; 57(3A):683-5. PubMed ID: 10667297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia.
    Ansved T; Odergren T; Borg K
    Neurology; 1997 May; 48(5):1440-2. PubMed ID: 9153487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: polyradiculoneuritis after botulinum toxin therapy for cervical dystonia.
    Tarsy D
    Clin Neuropharmacol; 2001; 24(2):122-3. PubMed ID: 11307052
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain Metabolic Changes of Cervical Dystonia with Spinocerebellar Ataxia Type 1 after Botulinum Toxin Therapy.
    Kikuchi A; Takeda A; Sugeno N; Miura E; Kato K; Hasegawa T; Baba T; Konno M; Oshima R; Watanuki S; Hiraoka K; Tashiro M; Aoki M
    Intern Med; 2016; 55(14):1919-22. PubMed ID: 27432104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group.
    Kessler KR; Skutta M; Benecke R
    J Neurol; 1999 Apr; 246(4):265-74. PubMed ID: 10367694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
    Adler CH; Factor SA; Brin M; Sethi KD
    Mov Disord; 2002 Jan; 17(1):158-61. PubMed ID: 11835455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.
    Dowson AJ; Kilminster SG; Salt R
    Drugs R D; 2008; 9(3):147-58. PubMed ID: 18457467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
    Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
    Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of oromandibular dystonia with botulinum A toxin: a series of cases.
    Teemul TA; Patel R; Kanatas A; Carter LM
    Br J Oral Maxillofac Surg; 2016 Dec; 54(10):1080-1084. PubMed ID: 27776922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin treatment for upper airway collapse resulting from temporomandibular joint dislocation due to jaw-opening dystonia.
    Yoshida K; Iizuka T
    Cranio; 2006 Jul; 24(3):217-22. PubMed ID: 16933464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study.
    Wissel J; Kanovsky P; Ruzicka E; Bares M; Hortova H; Streitova H; Jech R; Roth J; Brenneis C; Müller J; Schnider P; Auff E; Richardson A; Poewe W
    J Neurol; 2001 Dec; 248(12):1073-8. PubMed ID: 12013585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based medicine in botulinum toxin therapy for cervical dystonia.
    Ceballos-Baumann AO
    J Neurol; 2001 Apr; 248 Suppl 1():14-20. PubMed ID: 11357233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laryngeal dystonia: case report and treatment with botulinum toxin.
    Santos VJ; Mattioli FM; Mattioli WM; Daniel RJ; Cruz VP
    Braz J Otorhinolaryngol; 2006; 72(3):425-7. PubMed ID: 17119783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Pulmonary Function During Botulinum Toxin A Therapy for Chronic Migraines in a 17-Year-Old Female.
    Oliver JD; Boesch RP; Mack KJ
    Headache; 2018 Sep; 58(8):1259-1261. PubMed ID: 30033516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.